Institutional Ownership Aurinia Pharmaceuticals Inc. (AUPH)
This table provides information about the institutional ownership of Aurinia Pharmaceuticals Inc. (AUPH). We have compiled data on the 227 institutions that hold shares in the stock, with a total of 58.9 Million shares, which have been reported (via 13F filing form) to have a value of $467 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Spotlight Asset Group, Inc.
Oakbrook Terrace, IL |
Jul 23, 2024 Q2 2024 |
75
shares
|
$603
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Time Scale Financial, Inc.
|
Jul 26, 2023 Q2 2023 |
64
shares
|
$515
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Parallel Advisors, LLC
|
Feb 10, 2025 Q4 2024 |
43
shares
|
$346
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
Feb 13, 2025 Q4 2024 |
40
shares
|
$322
0.0% of portfolio
|
Q1 2018
Added 35.23%
|
|
|
Td Waterhouse Canada Inc.
Toronto, A6 |
Feb 13, 2025 Q4 2024 |
20
shares
|
$161
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Farther Finance Advisors, LLC
San Francisco, CA |
Feb 07, 2025 Q4 2024 |
18
shares
|
$144
0.0% of portfolio
|
Q4 2024
Reduced 35.71%
|
|
|
First Horizon Advisors, Inc.
|
Feb 03, 2025 Q4 2024 |
17
shares
|
$136
0.0% of portfolio
|
Q4 2022
Reduced 88.82%
|
|
|
Huntington National Bank
Columbus, OH |
Feb 12, 2025 Q4 2024 |
2
shares
|
$16
0.0% of portfolio
|
Q2 2023
Reduced 99.68%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|